AmpliPhi Biosciences Corporation

(APHB)

By |

Profile

Ampliphi Biosciences Corp is a clinical-stage biotechnology company focused on the development of bacteriophage-based therapies for the treatment of antibiotic-resistant bacterial infections. The company is developing phage product candidates using a proprietary discovery and development platform, which is designed for rapid identification, characterization, and manufacturing of multiple phage therapeutics. The lead product candidates are AB-SA01, which is developed for the treatment of Staphylococcus aureus infections; AB-PA01 for the treatment of P.aeruginosa infections; and AB-CD01 for the treatment of C. difficile infections.

Contact Information

Website: www.ampliphibio.com
Email: IR@ampliphibio.com
Main Phone: +1 858 829-0829
Address: 3579 Valley Centre Drive
Address 2: Suite 100
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92130

Issuer Information

Exchange: AMX
CEO: Paul C. Grint
Employees: 34
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 0.21 $ -0.0001 (-0.05%)
Last Price 0.21 Change $ -0.0001 Change % -0.05 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.22 High 0.24 Low 0.20 Prev Close 0.21
Last Trade Volume 407,448 52 Wk Hi 2.05 52 Wk Low 0.20
Market Cap 6.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 32,293,308.00 EPS (TTM) -0.53 PE Ratio N/A Exchange NYSE American
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 4
Number of Buys 1 4
Number of Sells 0 0
Net Activity 181820 293191
Last 10 Buys Shares
Jeremy L. Curnock Cook 1,000
Jeremy L. Curnock Cook 1,000
Jeremy L. Curnock Cook 1,000
Jeremy L. Curnock Cook 1,000
Jeremy L. Curnock Cook 1,000
Jeremy L. Curnock Cook 1,000
Louis C. Drapeau 1,000
M. Scott Salka 1,000
Wendy Johnson 1,000
Last 10 Sell Shares
Randal J. Kirk 1,000
Randal J. Kirk 1,000
Randal J. Kirk 1,000
Randal J. Kirk 1,000
Randal J. Kirk 1,000
Randal J. Kirk 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 6 6 6 6
Low Target Price Estimate 4 4 4 4
Mean Target Price Estimate 5 5 5 5
Standard Deviation 1.41 1.41 1.41 1.41
Date of Most Recent Estimate 05/17/18 05/17/18 05/17/18 06/12/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1